Published in Clin Exp Immunol on June 01, 2007
Innate immune gene polymorphisms in tuberculosis. Infect Immun (2012) 1.89
SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis. PLoS One (2011) 1.70
A meta-analysis of P2X7 gene-762T/C polymorphism and pulmonary tuberculosis susceptibility. PLoS One (2014) 1.45
A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs (2011) 1.39
P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. J Immunol (2010) 1.33
Genetics of the P2X7 receptor and human disease. Purinergic Signal (2009) 1.19
The role of the P2X₇ receptor in infectious diseases. PLoS Pathog (2011) 1.15
The role of reactive-oxygen-species in microbial persistence and inflammation. Int J Mol Sci (2011) 1.08
P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways. Purinergic Signal (2009) 1.02
Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation. Infect Immun (2010) 0.99
Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions. Immunol Res (2011) 0.99
Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis. PLoS Pathog (2014) 0.98
Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation. Recent Pat CNS Drug Discov (2010) 0.97
Insights into the Molecular Mechanisms Underlying Mammalian P2X7 Receptor Functions and Contributions in Diseases, Revealed by Structural Modeling and Single Nucleotide Polymorphisms. Front Pharmacol (2013) 0.97
The P2X(7) receptor and intracellular pathogens: a continuing struggle. Purinergic Signal (2009) 0.93
Cell signaling via the P2X(7) nucleotide receptor: linkage to ROS production, gene transcription, and receptor trafficking. Purinergic Signal (2009) 0.91
Adenosine modulates Toll-like receptor function: basic mechanisms and translational opportunities. Expert Rev Anti Infect Ther (2011) 0.90
Potential for developing purinergic drugs for gastrointestinal diseases. Inflamm Bowel Dis (2014) 0.90
Standardized method to minimize variability in a functional P2X(7) flow cytometric assay for a multi-center clinical trial. Cytometry B Clin Cytom (2008) 0.84
Polymorphisms of the NRAMP1 gene: distribution and susceptibility to the development of pulmonary tuberculosis in the Greek population. Med Sci Monit (2011) 0.81
Non-synonymous single nucleotide polymorphisms in the P2X receptor genes: association with diseases, impact on receptor functions and potential use as diagnosis biomarkers. Int J Mol Sci (2014) 0.80
Single Nucleotide Polymorphisms in P2X7 Gene Are Associated with Serum Immunoglobulin G Responses to Mycobacterium tuberculosis in Tuberculosis Patients. Dis Markers (2015) 0.75
The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science (1996) 7.10
Tuberculosis. Lancet (2003) 6.39
Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med (1998) 6.14
Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science (1989) 5.61
Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proc Natl Acad Sci U S A (2004) 2.86
Genetics of susceptibility to human infectious disease. Nat Rev Genet (2001) 2.80
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J Biol Chem (1997) 2.78
Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2000) 2.63
Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis. J Immunol (2005) 2.49
ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity (1997) 2.39
Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J Exp Med (1997) 2.34
Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages. J Exp Med (2000) 1.83
Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression. J Exp Med (1994) 1.82
A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J Biol Chem (2001) 1.77
Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis (2002) 1.74
Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J Exp Med (1998) 1.73
SLC11A1 (formerly NRAMP1) and disease resistance. Cell Microbiol (2001) 1.68
Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products. J Immunol (1997) 1.63
ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. J Immunol (2001) 1.60
P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release. J Immunol (2003) 1.52
P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J Biol Chem (2002) 1.48
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J Immunol (2005) 1.47
A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem (2005) 1.47
Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes. J Immunol (2004) 1.40
The NRAMP family of metal-ion transporters. Biochim Biophys Acta (2006) 1.38
ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J Immunol (2000) 1.38
A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. J Immunol (2003) 1.36
Natural-resistance-associated macrophage protein 1 is an H+/bivalent cation antiporter. Biochem J (2001) 1.36
Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood (1998) 1.34
Genomic organization and sequence of the human NRAMP gene: identification and mapping of a promoter region polymorphism. Mol Med (1995) 1.32
VDR and NRAMP1 gene polymorphisms in susceptibility to pulmonary tuberculosis among the Chinese Han population: a case-control study. Int J Tuberc Lung Dis (2004) 1.32
Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease. Proc Natl Acad Sci U S A (2005) 1.30
SLC11A1 (formerly NRAMP1) gene polymorphisms and tuberculosis susceptibility: a meta-analysis. Int J Tuberc Lung Dis (2006) 1.28
3'UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans. Int J Tuberc Lung Dis (2000) 1.26
Role of iron in Nramp1-mediated inhibition of mycobacterial growth. Infect Immun (1999) 1.24
Association of a polymorphism in the P2X7 gene with tuberculosis in a Gambian population. J Infect Dis (2002) 1.23
Gene structure and chromosomal localization of the human P2X7 receptor. Receptors Channels (1998) 1.19
P2X7 receptor polymorphism impairs extracellular adenosine 5'-triphosphate-induced interleukin-18 release from human monocytes. Genes Immun (2004) 1.07
Glu496Ala polymorphism of human P2X7 receptor does not affect its electrophysiological phenotype. Am J Physiol Cell Physiol (2002) 1.06
Variants of the natural resistance-associated macrophage protein 1 gene (NRAMP1) are associated with severe forms of pulmonary tuberculosis. Clin Infect Dis (2005) 1.06
Nramp1 functionality increases inducible nitric oxide synthase transcription via stimulation of IFN regulatory factor 1 expression. J Immunol (2003) 1.05
P2X7 receptor-dependent cell death is modulated during murine T cell maturation and mediated by dual signaling pathways. J Immunol (2006) 0.99
Nramp1-mediated innate resistance to intraphagosomal pathogens is regulated by IRF-8, PU.1, and Miz-1. J Biol Chem (2003) 0.98
Variations in the NRAMP1 gene and susceptibility of tuberculosis in Taiwanese. Int J Tuberc Lung Dis (2002) 0.97
Analyses of the NRAMP1 and IFN-gammaR1 genes in women with Mycobacterium avium-intracellulare pulmonary disease. Am J Respir Crit Care Med (1998) 0.93
Solute carrier 11a1 (Slc11a1; formerly Nramp1) regulates metabolism and release of iron acquired by phagocytic, but not transferrin-receptor-mediated, iron uptake. Biochem J (2002) 0.92
Expression and function of the purinergic receptor P2X7 in patients with pulmonary tuberculosis. Clin Exp Immunol (2006) 0.89
ATP and control of intracellular growth of mycobacteria by T cells. Infect Immun (2002) 0.88
Iron chelators modulate the fusogenic properties of Salmonella-containing phagosomes. Proc Natl Acad Sci U S A (2003) 0.86
CD43 interacts with moesin and ezrin and regulates its redistribution to the uropods of T lymphocytes at the cell-cell contacts. Blood (1998) 1.91
Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease. Am J Respir Crit Care Med (2001) 1.64
Pacemaker endocarditis: approach for lead extraction in endocarditis with large vegetations. Ann Thorac Surg (2001) 1.47
Parosteal osteoma of the iliac bone. Skeletal Radiol (1998) 1.44
Epidermal Langerhans cells in Actinic Prurigo: a comparison between lesional and non-lesional skin. J Eur Acad Dermatol Venereol (2009) 1.38
Cardiac myxomas: surgical treatment, long-term results and recurrence. J Cardiovasc Surg (Torino) (1993) 1.30
A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections. Surg Gynecol Obstet (1982) 1.28
Thalidomide--effect on T cell subsets as a possible mechanism of action. Int J Lepr Other Mycobact Dis (1985) 1.24
Human C4 haplotypes with duplicated C4A or C4B. Am J Hum Genet (1984) 1.24
Influence of glucose on the sex ratio of bovine IVM/IVF embryos cultured in vitro. Reprod Fertil Dev (2001) 1.19
Gene frequencies and admixture estimates in four Mexican urban centers. Hum Biol (1990) 1.18
Actinic prurigo: an update. Int J Dermatol (1995) 1.17
Fulminant amebic colitis: analysis of 55 cases. Dis Colon Rectum (1997) 1.16
Immunogenetics of human American cutaneous leishmaniasis. Study of HLA haplotypes in 24 families from Venezuela. Hum Immunol (1991) 1.15
Clinical and immunogenetic characterization of Mexican patients with 'rhupus'. Lupus (2002) 1.13
Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum (1997) 1.09
Effect of arsenic on regulatory T cells. J Clin Immunol (2009) 1.07
Therapy with statins in patients with refractory rheumatic diseases: a preliminary study. Lupus (2003) 1.07
Gene frequencies and admixture estimates in a Mexico City population. Am J Phys Anthropol (1986) 1.05
High antibody levels to the mycobacterial fibronectin-binding antigen of 30-31 kD in tuberculosis and lepromatous leprosy. Clin Exp Immunol (1992) 1.00
Extended MHC haplotypes in 21-hydroxylase-deficiency congenital adrenal hyperplasia: shared genotypes in unrelated patients. Lancet (1983) 1.00
Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies. Ann Rheum Dis (2002) 0.99
HLA-B alleles and complotypes in Mexican patients with seronegative spondyloarthropathies. Ann Rheum Dis (1994) 0.96
HLA genes in Mexican Mazatecans, the peopling of the Americas and the uniqueness of Amerindians. Tissue Antigens (2000) 0.95
IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus. Rheumatology (Oxford) (2005) 0.95
Sulfite sensitivity: relationship between sulfite plasma levels and bronchospasm: case report. Ann Allergy (1989) 0.94
Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial. J Rheumatol (1984) 0.93
Accurate length adjustment of right or circumflex coronary artery bypass grafts. J Cardiovasc Surg (Torino) (1987) 0.93
Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients. Ann Rheum Dis (2002) 0.93
Penetrating anti-DNA monoclonal antibodies induce activation of human peripheral blood mononuclear cells. J Autoimmun (1998) 0.92
DNA sequencing of HLA-B alleles in Mexican patients with Takayasu arteritis. Int J Cardiol (2000) 0.92
Roles of chemokines and receptor polarization in NK-target cell interactions. J Immunol (1998) 0.92
Immunogenetics and clinical aspects of Takayasu's arteritis patients in a Mexican Mestizo population. Clin Exp Rheumatol (2001) 0.91
New piophilid in town: the first Palaearctic record of Piophila megastigmata and its coexistence with Piophila casei in central Spain. Med Vet Entomol (2010) 0.91
Gene frequencies and admixture estimates in the state of Puebla, Mexico. Am J Phys Anthropol (1988) 0.91
Biological relevance of the polymorphism in the CCR5 gene in refractory and non-refractory rheumatoid arthritis in Mexicans. Clin Exp Rheumatol (2003) 0.91
Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis. Clin Exp Immunol (2005) 0.91
Distribution of ICAM-3-bearing cells in normal human tissues. Expression of a novel counter-receptor for LFA-1 in epidermal Langerhans cells. Am J Pathol (1993) 0.90
Expression and function of the purinergic receptor P2X7 in patients with pulmonary tuberculosis. Clin Exp Immunol (2006) 0.89
Expression of L-selectin, CD43, and CD44 in synovial fluid neutrophils from patients with inflammatory joint diseases. Evidence for a soluble form of L-selectin in synovial fluid. Arthritis Rheum (1994) 0.89
Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus. Scand J Immunol (2006) 0.88
Allele frequencies for 15 autosomal STR loci and admixture estimates in Puerto Rican Americans. Forensic Sci Int (2006) 0.88
Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus. Lupus (1997) 0.88
Effect of arsenic, cadmium and lead on the induction of apoptosis of normal human mononuclear cells. Clin Exp Immunol (2002) 0.88
Immunogenetic profile of multiple sclerosis in Mexicans. Hum Immunol (1986) 0.87
[Analysis of genetic polymorphism of the HLA-B and HLA-DR loci in patients with dermatophytic onychomycosis and in their first-degree relatives]. Actas Dermosifiliogr (2011) 0.87
Recovery of ventricular function with a left ventricular axial pump in a patient with end-stage toxic cardiomyopathy not a candidate for heart transplantation: first experience in Spain. Transplant Proc (2009) 0.87
Analysis of expression and function of the inhibitory receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE). J Autoimmun (2007) 0.87
HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis. Neurology (2000) 0.87
HLA antigens and juvenile onset spondyloarthritides: negative association with non-B27 alleles. Clin Exp Rheumatol (2005) 0.86
Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun (2001) 0.85
Pentoxifylline inhibits adhesion and activation of human T lymphocytes. J Immunol (1998) 0.85
Immunology of the cutaneous disorders of pregnancy. Int J Dermatol (1999) 0.85
Decreased blood levels of B lymphocytes and NK cells in patients with systemic lupus erythematosus (SLE) infected with papillomavirus (HPV). Arch Dermatol Res (2012) 0.84
Magnetic resonance imaging in patients with rheumatoid arthritis with complete remission treated with disease-modifying antirheumatic drugs or anti-tumour necrosis factor alpha agents. Ann Rheum Dis (2007) 0.84
Immunologic, genetic and social human risk factors associated to histoplasmosis: studies in the State of Guerrero, Mexico. Mycopathologia (1997) 0.84
Apolipoprotein E polymorphism in the Indian and Mestizo populations of Mexico. Hum Biol (2000) 0.84
Deficit irrigation and rootstock: their effects on water relations, vegetative development, yield, fruit quality and mineral nutrition of Clemenules mandarin. Tree Physiol (2006) 0.84
Haplotype distribution of class II MHC genes in Mexican patients with systemic lupus erythematosus. Scand J Rheumatol (1998) 0.83
Identification of two homologous antigenic peptides derived from L1 HPV-16 and 18 proteins specific for the HLA-B*3901 allele. Arch Virol (2002) 0.83
Innate immune mechanisms in the pathogenesis of systemic lupus erythematosus (SLE). Immunol Lett (2001) 0.83
Expression and functional significance of an activation-dependent epitope of the beta 1 integrins in chronic inflammatory diseases. Eur J Immunol (1995) 0.82
Comparison of dexketoprofen trometamol and ketoprofen in the treatment of osteoarthritis of the knee. J Clin Pharmacol (1998) 0.82
Surgical treatment of Brucella endocarditis. Cardiovasc Surg (1996) 0.82
[Alleles of the major histocompatibility system associated with susceptibility to the development of Takayasu's arteritis]. Gac Med Mex (2002) 0.82
Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus. J Autoimmun (1998) 0.82
Relationship between sex ratio and time of insemination according to both time of ovulation and maturational state of oocyte. Zygote (1999) 0.82
Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level. Transpl Immunol (2009) 0.82
Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study. Clin Exp Immunol (2014) 0.82
Further evidence of the role of HLA-DR4 in the genetic susceptibility to actinic prurigo. J Am Acad Dermatol (1997) 0.81
Melatonin protects against renal oxidative stress after obstructive jaundice in rats. Eur J Pharmacol (2001) 0.81
Increased frequency of HLA-DR3 and complotype SCO1 in Mexican mestizo children with amoebic abscess of the liver. Parasite Immunol (1996) 0.81
Immunopathology of polymorphous light eruption. T lymphocytes in blood and skin. J Am Acad Dermatol (1984) 0.81
Class II major histocompatibility complex typing across the ethnic barrier in pemphigoid gestationis. A study in Mexicans. Int J Dermatol (1999) 0.81
Conservative operation for mitral stenosis. Independent determinants of late results. J Thorac Cardiovasc Surg (1988) 0.81
Treating severe systemic lupus erythematosus with rituximab. An open study. Reumatol Clin (2009) 0.81
HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis. Eur J Neurol (2003) 0.81
Expression and function of IL-10R in mononuclear cells from patients with systemic lupus erythematosus. Scand J Rheumatol (2006) 0.80
Production of antimicrobial peptides is preserved in aging. Clin Immunol (2013) 0.80